Literature DB >> 8318718

The competitive and noncompetitive antagonism of receptor-mediated drug actions in the presence of spare receptors.

B T Zhu1.   

Abstract

According to the original receptor occupancy theory proposed by Clark in the 1930s, the percent occupancy of total available receptors by an agonist is linearly related to the response (or effect). However, the first recognition of "receptor reserve" or "spare receptors" mainly by Furchgott and Stephenson in separate studies about two decades ago has profoundly modified the original receptor occupancy theory, that is, the receptor occupancy is not directly proportional to the responses, and the ED50 (or EC50) could be much lower than the equilibrium dissociation constant (Kd). To date, the receptor reserve phenomenon has been characterized in an increasing number of receptor systems. In theory, spare receptors may influence the profile of dose-response (D-R) relationship as well as that of the competitive or noncompetitive antagonism of receptor-mediated drug actions.

Mesh:

Substances:

Year:  1993        PMID: 8318718     DOI: 10.1016/1056-8719(93)90055-j

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  13 in total

1.  Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathways.

Authors:  Kyle K Henderson; Kenneth L Byron
Journal:  J Appl Physiol (1985)       Date:  2007-01-04

2.  Refolding of misfolded mutant GPCR: post-translational pharmacoperone action in vitro.

Authors:  Jo Ann Janovick; Shaun P Brothers; Anda Cornea; Eugene Bush; Mark T Goulet; Wallace T Ashton; Daryl R Sauer; Fortuna Haviv; Jonathan Greer; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2007-05-03       Impact factor: 4.102

3.  Quantitative analysis of receptor tyrosine kinase-effector coupling at functionally relevant stimulus levels.

Authors:  Simin Li; Devayani Bhave; Jennifer M Chow; Thomas V Riera; Sandra Schlee; Simone Rauch; Mariya Atanasova; Richard L Cate; Adrian Whitty
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

4.  bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.

Authors:  Thomas E Wooters; Andrew M Smith; Marharyta Pivavarchyk; Kiran B Siripurapu; J Michael McIntosh; Zhenfa Zhang; Peter A Crooks; Michael T Bardo; Linda P Dwoskin
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

5.  New insights into receptor theory, as provided by an artificial partial agonist made-to-measure.

Authors:  T J Feuerstein; W Sauermann; C Allgaier; E Agneter; E A Singer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

6.  Variable Dependence of Signaling Output on Agonist Occupancy of Ste2p, a G Protein-coupled Receptor in Yeast.

Authors:  Rajashri Sridharan; Sara M Connelly; Fred Naider; Mark E Dumont
Journal:  J Biol Chem       Date:  2016-09-19       Impact factor: 5.157

7.  Participation of the endoplasmic reticulum protein chaperone thio-oxidoreductase in gonadotropin-releasing hormone receptor expression at the plasma membrane.

Authors:  W Lucca-Junior; J A Janovick; P M Conn
Journal:  Braz J Med Biol Res       Date:  2009-02       Impact factor: 2.590

8.  Noncatalytic Bruton's tyrosine kinase activates PLCγ2 variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cells.

Authors:  Martin Wist; Laura Meier; Orit Gutman; Jennifer Haas; Sascha Endres; Yuan Zhou; Reinhild Rösler; Sebastian Wiese; Stephan Stilgenbauer; Elias Hobeika; Yoav I Henis; Peter Gierschik; Claudia Walliser
Journal:  J Biol Chem       Date:  2020-03-17       Impact factor: 5.157

9.  Sphingolipids function as downstream effectors of a fungal PAQR.

Authors:  Nancy Y Villa; Brian R Kupchak; Ibon Garitaonandia; Jessica L Smith; Emilio Alonso; Charlene Alford; L Ashley Cowart; Yusuf A Hannun; Thomas J Lyons
Journal:  Mol Pharmacol       Date:  2008-12-09       Impact factor: 4.436

10.  Sequential mechanisms underlying concentration invariance in biological olfaction.

Authors:  Thomas A Cleland; Szu-Yu T Chen; Katarzyna W Hozer; Hope N Ukatu; Kevin J Wong; Fangfei Zheng
Journal:  Front Neuroeng       Date:  2012-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.